{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T02:40:43Z","timestamp":1783478443580,"version":"3.55.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008486","name":"Schweizerische Multiple Sklerose Gesellschaft","doi-asserted-by":"publisher","award":["SMSG-2020\u20131"],"award-info":[{"award-number":["SMSG-2020\u20131"]}],"id":[{"id":"10.13039\/501100008486","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.msard.2023.104592","type":"journal-article","created":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T02:18:12Z","timestamp":1677637092000},"page":"104592","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["The serum kynurenine pathway metabolic profile is associated with overweight and obesity in multiple sclerosis"],"prefix":"10.1016","volume":"72","author":[{"given":"Marie","family":"Kupjetz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Patt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas","family":"Joisten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per Magne","family":"Ueland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"McCann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Gonzenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Bansi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Zimmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.msard.2023.104592_bib0001","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1212\/CON.0000000000001136","article-title":"Epidemiology and pathophysiology of multiple sclerosis","volume":"28","author":"Ward","year":"2022","journal-title":"Continuum"},{"issue":"11","key":"10.1016\/j.msard.2023.104592_bib0002","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/s41582-021-00556-y","article-title":"Apparent changes in the epidemiology and severity of multiple sclerosis","volume":"17","author":"Koch-Henriksen","year":"2021","journal-title":"Nat. Rev. Neurol."},{"issue":"2","key":"10.1016\/j.msard.2023.104592_bib0004","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/acn3.51291","article-title":"Obesity and the risk of multiple sclerosis. The role of Leptin","volume":"8","author":"Marrodan","year":"2021","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"7","key":"10.1016\/j.msard.2023.104592_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.29245\/2572.942X\/2016\/7.1064","article-title":"Obesity and multiple sclerosis susceptibility: a review","volume":"1","author":"Gianfrancesco","year":"2016","journal-title":"J. Neurol. Neuromedicine"},{"issue":"1","key":"10.1016\/j.msard.2023.104592_bib0006","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nrneurol.2016.187","article-title":"Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis","volume":"13","author":"Olsson","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.msard.2023.104592_bib0007","article-title":"Association of obesity with disease outcome in multiple sclerosis","author":"Lutfullin","year":"2022","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2023.104592_bib0015","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0021-9258(19)84026-7","article-title":"Enzymic synthesis of niacin nucleotides from 3-hydroxyanthranilic acid in mammalian liver","volume":"238","author":"Nishizuka","year":"1963","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.msard.2023.104592_bib0008","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S1474-4422(17)30084-4","article-title":"Neurological consequences of obesity","volume":"16","author":"O'Brien","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2023.104592_bib0009","doi-asserted-by":"crossref","DOI":"10.1177\/1178646917691938","article-title":"Kynurenine pathway of tryptophan metabolism: regulatory and functional aspects","volume":"10","author":"Badawy","year":"2017","journal-title":"Int. J. Tryptophan Res."},{"issue":"11","key":"10.1016\/j.msard.2023.104592_bib0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0258204","article-title":"Characterizing the distributions of IDO-1 expressing macrophages\/microglia in human and murine brains and evaluating the immunological and physiological roles of IDO-1 in RAW264.7\/BV-2 cells","volume":"16","author":"Ji","year":"2021","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.msard.2023.104592_bib0011","doi-asserted-by":"crossref","first-page":"5809","DOI":"10.4049\/jimmunol.170.12.5809","article-title":"Tryptophan catabolism and regulation of adaptive immunity","volume":"170","author":"Mellor","year":"2003","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.msard.2023.104592_bib0012","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2174\/1389200024605082","article-title":"Neopterin as a marker for immune system activation","volume":"3","author":"Murr","year":"2002","journal-title":"Curr. Drug Metab."},{"issue":"6","key":"10.1016\/j.msard.2023.104592_bib0013","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1111\/j.1471-4159.1991.tb03460.x","article-title":"Blood-brain barrier transport of kynurenines: implications for brain synthesis and metabolism","volume":"56","author":"Fukui","year":"1991","journal-title":"J. Neurochem."},{"key":"10.1016\/j.msard.2023.104592_bib0014","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3389\/fimmu.2016.00246","article-title":"Current evidence for a role of the kynurenine pathway of tryptophan metabolism in multiple sclerosis","volume":"7","author":"Lovelace","year":"2016","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.msard.2023.104592_bib0016","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1523\/JNEUROSCI.10-09-02965.1990","article-title":"Cerebral synthesis and release of kynurenic acid: an endogenous antagonist of excitatory amino acid receptors","volume":"10","author":"Swartz","year":"1990","journal-title":"J. Neurosci."},{"key":"10.1016\/j.msard.2023.104592_bib0017","doi-asserted-by":"crossref","first-page":"41473","DOI":"10.1038\/srep41473","article-title":"Kynurenine pathway metabolomics predicts and provides mechanistic insight into multiple sclerosis progression","volume":"7","author":"Lim","year":"2017","journal-title":"Sci Rep."},{"issue":"1","key":"10.1016\/j.msard.2023.104592_bib0018","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/cei.12092","article-title":"A community-based study on determinants of circulating markers of cellular immune activation and kynurenines: the Hordaland Health Study","volume":"173","author":"Theofylaktopoulou","year":"2013","journal-title":"Clin. Exp. Immunol."},{"issue":"2","key":"10.1016\/j.msard.2023.104592_bib0019","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"issue":"11","key":"10.1016\/j.msard.2023.104592_bib0020","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.msard.2023.104592_bib0021","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12883-021-02084-0","volume":"21","author":"Patt","year":"2021","journal-title":"BMC Neurol."},{"issue":"9","key":"10.1016\/j.msard.2023.104592_bib0022","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/rcm.4013","article-title":"Quantitative profiling of biomarkers related to B-vitamin status, tryptophan metabolism and inflammation in human plasma by liquid chromatography\/tandem mass spectrometry","volume":"23","author":"Midttun","year":"2009","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.msard.2023.104592_bib0003","unstructured":"Multiple Sclerosis International Federation. Atlas of MS 2020 \u2013 Epidemiology report. Accessed March 2, 2023. https:\/\/www.atlasofms.org\/map\/global\/epidemiology\/numberofpeoplewith-ms."},{"key":"10.1016\/j.msard.2023.104592_bib0023","unstructured":"World Health Organization. Obesity and overweight. Accessed December 8, 2022. https:\/\/www.who.int\/newsroom\/fact-sheets\/detail\/obesity-and-overweigh."},{"key":"10.1016\/j.msard.2023.104592_bib0024","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3389\/fimmu.2020.00557","article-title":"Tryptophan metabolic pathways are altered in obesity and are associated with systemic inflammation","volume":"11","author":"Cussotto","year":"2020","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.msard.2023.104592_bib0025","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1002\/oby.21199","article-title":"The kynurenine pathway is activated in human obesity and shifted toward kynurenine monooxygenase activation","volume":"23","author":"Favennec","year":"2015","journal-title":"obes."},{"issue":"9","key":"10.1016\/j.msard.2023.104592_bib0026","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1021\/acs.jproteome.6b01062","article-title":"Blood metabolic signatures of body mass index: a targeted metabolomics study in the EPIC cohort","volume":"16","author":"Carayol","year":"2017","journal-title":"J. Proteome Res."},{"issue":"1","key":"10.1016\/j.msard.2023.104592_bib0027","article-title":"Adipocyte-derived kynurenine promotes obesity and insulin resistance by activating the AhR\/STAT3\/IL-6 signaling","volume":"13","author":"Huang","year":"2022","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.msard.2023.104592_bib0028","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0159548","article-title":"Metabolic profiles of obesity in American Indians: the strong heart family study","volume":"11","author":"Zhao","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.msard.2023.104592_bib0029","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/oby.20491","article-title":"Obesity-related dysregulation of the tryptophan-kynurenine metabolism: role of age and parameters of the metabolic syndrome","volume":"22","author":"Mangge","year":"2014","journal-title":"Obesity"},{"issue":"2","key":"10.1016\/j.msard.2023.104592_bib0030","doi-asserted-by":"crossref","first-page":"R135","DOI":"10.1152\/ajpregu.00373.2011","article-title":"Tryptophan metabolism activation by indoleamine 2,3-dioxygenase in adipose tissue of obese women: an attempt to maintain immune homeostasis and vascular tone","volume":"303","author":"Wolowczuk","year":"2012","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"1","key":"10.1016\/j.msard.2023.104592_bib0031","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1166\/ajnn.2011.1024","article-title":"Neopterin, a marker of interferon-gamma-inducible inflammation, correlates with pyridoxal-5\u2032-phosphate, waist circumference, HDL-cholesterol, insulin resistance and mortality risk in adult Boston Community Dwellers of Puerto Rican Origin","volume":"3","author":"Oxenkrug","year":"2011","journal-title":"Am. J. Neuroprot. Neuroregen."},{"issue":"3","key":"10.1016\/j.msard.2023.104592_bib0032","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s430-001-8023-3","article-title":"Neopterin production and tryptophan degradation in humans infected by Streptococcus pyogenes","volume":"189","author":"Murr","year":"2001","journal-title":"Med. Microbiol. Immunol."},{"issue":"1\u20132","key":"10.1016\/j.msard.2023.104592_bib0033","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.cca.2005.06.013","article-title":"Monitoring tryptophan metabolism in chronic immune activation","volume":"364","author":"Schr\u00f6cksnadel","year":"2006","journal-title":"Clin. Chim. Acta"},{"issue":"5","key":"10.1016\/j.msard.2023.104592_bib0034","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1381\/096089206776945066","article-title":"Bariatric surgery cannot prevent tryptophan depletion due to chronic immune activation in morbidly obese patients","volume":"16","author":"Brandacher","year":"2006","journal-title":"Obes. Surg."},{"key":"10.1016\/j.msard.2023.104592_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103667","article-title":"Association between microglial activation and serum kynurenine pathway metabolites in multiple sclerosis patients","volume":"59","author":"Saraste","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"12","key":"10.1016\/j.msard.2023.104592_bib0036","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1093\/aje\/kwq306","article-title":"Comparison of dual-energy x-ray absorptiometric and anthropometric measures of adiposity in relation to adiposity-related biologic factors","volume":"172","author":"Sun","year":"2010","journal-title":"Am. J. Epidemiol."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034823000962?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034823000962?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T09:04:20Z","timestamp":1761901460000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034823000962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":36,"alternative-id":["S2211034823000962"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2023.104592","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The serum kynurenine pathway metabolic profile is associated with overweight and obesity in multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2023.104592","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104592"}}